Related Experiment Video
Updated: May 16, 2026

Modifying Levels of Maternal Dietary Folic Acid or Choline to Study the Impact of Deficiencies on Offspring Health Outcomes
Published on: June 28, 2024
Multiple-micronutrient supplementation for women during pregnancy
Batool A Haider1, Zulfiqar A Bhutta
1Departments of Epidemiology and Nutrition, Harvard School of Public Health, Boston, MA, USA.
Multiple-micronutrient supplements (MMS) during pregnancy significantly reduced low birthweight and small-for-gestational age (SGA) babies compared to iron and folate alone. More evidence is needed to guide universal policy changes for MMS.
Area of Science:
- Obstetrics and Gynecology
- Maternal and Child Health
- Nutritional Science
Background:
- Multiple-micronutrient deficiencies are common in low- to middle-income countries and are worsened during pregnancy.
- Increased nutritional demands in pregnancy can lead to adverse maternal outcomes.
- Limited evidence exists on the effectiveness of multiple-micronutrient supplements (MMS) during pregnancy.
Purpose of the Study:
- To evaluate the maternal and infant benefits of MMS during pregnancy.
- To assess the risks of adverse events associated with MMS supplementation.
Main Methods:
- Systematic review of prospective randomized controlled trials (RCTs) identified through Cochrane Pregnancy and Childbirth Group's Trials Register and expert contact.
- Included 21 trials with 75,785 women, comparing MMS with iron and folate supplementation.
- Independent assessment of trial eligibility, quality, and data extraction by two reviewers.
Main Results:
- MMS significantly decreased the incidence of low birthweight babies (RR 0.89; 95% CI 0.83 to 0.94) and small-for-gestational age (SGA) babies (RR 0.87; 95% CI 0.81 to 0.95) compared to iron and folate.
- No significant differences were observed for preterm births, miscarriage, maternal mortality, perinatal mortality, stillbirths, or neonatal mortality.
- Insufficient data prevented assessment of other important outcomes like congenital anomalies, neurodevelopmental delay, and maternal well-being.
Conclusions:
- MMS demonstrate a significant benefit in reducing SGA and low birthweight babies.
- Further adequately powered trials are required to assess effects on mortality and morbidity outcomes.
- More research is needed on optimal MMS combinations and dosages, and their impact on routine antenatal care policies.
Related Concept Videos
Development of the Oral Microbiota
Mineral, Vitamin and Water Absorption
Bioavailability Study Design: Single Versus Multiple Dose Studies
Microbial Corrosion
Development of Human Microbiota
Microbial Nutrition
